DANTRIUM INTRAVEINEUX, lyophilizate for injection preparation bottle
Active ingredients: Dantrolene sodium
Commercialized according to BDPMDispensing in France: Prescription only
Lyophilizate for injection preparationbottleintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- DANTRIUM INTRAVEINEUX, lyophilisat pour préparation injectable
- Pharmaceutical form
- lyophilisat pour préparation injectable
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) en verre avec un dispositif de filtration à usage unique
- Marketing authorisation holder
- NORGINE (PAYS-BAS)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 30 Sept 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65074386CIP75548731CIP133400955487319Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DANTROLÈNE SODIQUElyophilisat | 0,020 g · un flacon de lyophilisat | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.